Progress, Potential, and Possibilities Podcast / Show Dr. Reynold Panettieri, MD - Rutgers University - Novel Therapeutic Approaches To Treat Airways Diseases
Dr. Reynold A. Panettieri, Jr, MD ( https://ritms.rutgers.edu/faculty/reynold-panettieri/ ) is the inaugural Director of the Institute for Translational Medicine and Science, and Vice Chancellor for Translational Medicine and Science, at Rutgers University, and previously served as the Director of the Airways Biology Initiative at the University of Pennsylvania.
Dr. Panettieri’s interests include the cellular and molecular mechanisms that regulate airway smooth muscle cell growth and the immunobiology of airway smooth muscle, which lead to the irreversible airflow obstruction and airway remodeling seen in patients with chronic severe asthma. Dr. Panettieri’s lab also focuses on cytosolic signaling pathways that mediate gene expression and alter myocyte growth.
Dr. Panettieri also served as the Deputy Director of the Center of Excellence in Environmental Toxicology at the University of Pennsylvania. He directed the human exposure chamber that defines the molecular mechanisms regulating ozone- and particulate matter-induced airway hyperresponsiveness.
In addition to his research and clinical interests, Dr. Panettieri served as chairperson of the NIH Lung Cellular, Molecular, and Immunobiology Study Section, is a member of the NIH Distinguished Editorial Panel, and is a member of the American Society for Clinical Investigation and Association of American Physicians.
Dr. Panettieri has an M.D. from University of Pennsylvania, and completed his
Residency and Fellowship at the Hospital of the University of Pennsylvania.
Important Episode Links -
As-Needed Albuterol–Budesonide in Mild Asthma
Published May 19, 2025
New England Journal Of Medicine -
https://www.nejm.org/doi/full/10.1056/NEJMoa2504544
BATURA Study Press Release -
https://www.astrazeneca.com/media-centre/press-releases/2025/statistically-significant-clinically-meaningful-batura-phase-iii-trial-provide-evidence-airsupra-standard-care-as-needed-rescue-treatment-asthma.html
AIRSUPRA (albuterol/budesonide) is a prescription medication used as a rescue inhaler for adults with asthma -
https://www.airsupra.com/
#ReynoldPanettieri #InstituteForTranslationalMedicineAndScience #RutgersUniversity #Asthma #COPD #ChronicObstructivePulmonaryDisease #AirwaysBiology #UniversityOfPennsylvania #Immunobiology #EnvironmentalHealth #Bronchiectasis #IdiopathicPulmonaryFibrosis #InterstitialLungDiseases #RescueInhalers #Albuterol #AIRSUPRA #Budesonide #Corticosteroid #BATURA #AstraZeneca #Exposome #RespiratoryDiseases #InflammatoryResponse #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research